Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — Capital Reinvestment Ratio
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Capital Reinvestment Ratio of 0.21x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥44.34 Million) in capital expenditures (CN¥9.15 Million). Check how tangible is Hainan Huluwa Pharmaceutical Group Co Lt's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hainan Huluwa Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Hainan Huluwa Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Hainan Huluwa Pharmaceutical Group Co Lt.
Annual Capital Reinvestment Ratio for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Hainan Huluwa Pharmaceutical Group Co Ltd from 2016 to 2025. See Hainan Huluwa Pharmaceutical Group Co Lt free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.61x | CN¥136.85 Million | CN¥83.67 Million | ▼ -96.5% |
| 2023 | 17.32x | CN¥28.25 Million | CN¥489.20 Million | ▲ +953.6% |
| 2022 | 1.64x | CN¥238.71 Million | CN¥392.32 Million | ▲ +22.4% |
| 2021 | 1.34x | CN¥102.48 Million | CN¥137.62 Million | ▼ -92.5% |
| 2020 | 18.01x | CN¥3.30 Million | CN¥59.42 Million | ▲ +4355.8% |
| 2019 | 0.40x | CN¥144.51 Million | CN¥58.40 Million | ▼ -82.4% |
| 2018 | 2.29x | CN¥31.80 Million | CN¥72.82 Million | ▲ +30.7% |
| 2017 | 1.75x | CN¥89.96 Million | CN¥157.58 Million | ▲ +177.6% |
| 2016 | 0.63x | CN¥64.96 Million | CN¥40.99 Million | — |